Tuberculosis News and Research

Latest Tuberculosis News and Research

UB program secures $12.8 million to improve the quality of global HIV research

The National Institutes of Health (NIH) has awarded $12.8 million to the University at Buffalo School of Pharmacy and Pharmaceutical Sciences to lead a clinical pharmacology quality assurance program for NIH-funded laboratories and research networks across the globe conducting HIV and infectious disease research.

16 Jun 2022

Early success of shorter tuberculosis treatment in Nigeria could pave the way for nationwide rollout

Early success with Nigeria's implementation of the new and shorter six-month tuberculosis treatment regimen in four states could pave the way for its rollout nationwide, says an expert.

10 Jun 2022

Inhaled vaccines provide better protection and stronger immunity than nasal sprays, study confirms

McMaster University scientists who compared respiratory vaccine-delivery systems have confirmed that inhaled aerosol vaccines provide far better protection and stronger immunity than nasal sprays.

10 Jun 2022

Pregnant people in Sub-Saharan Africa are at higher risk of complications and death from COVID-19

Pregnant people who are hospitalized with COVID-19 in Sub-Saharan Africa are dying at a rate far greater than pregnant people without COVID-19 and non-pregnant people with COVID-19, according to a new multicenter study encompassing six African countries.

8 Jun 2022

Highly sensitive blood test could give doctors a new tool to quickly identify and treat tuberculosis

Researchers at Tulane University School of Medicine have developed a new highly sensitive blood test for tuberculosis (TB) that screens for DNA fragments of the Mycobacterium tuberculosis bacteria that causes the deadly disease.

1 Jun 2022

Midwifery education in Bangladesh has greatly improved women’s access to safe childbirth, studies show

In association with the British High Commission in Bangladesh, the Directorate General of Nursing and Midwifery (DGNM) and the United Nations Population Fund (UNFPA) organised a dissemination seminar on Wednesday 1 June 2022, at the auditorium of DGNM in Dhaka, to share findings of two studies on midwifery in Bangladesh.

1 Jun 2022

New class of antibiotics found to be highly effective against drug-resistant tuberculosis

Infection by Mycobacterium tuberculosis kills 1.5 million people worldwide every year. Antibiotics to treat TB exist, but in recent years, multi-drug resistant (MDR), extensively drug-resistant (XDR) and totally drug-resistant (TDR) strains of the bacterium have developed.

31 May 2022

UK-Argentina led resolution could lead to better protection from future pandemics

Millions of people across the world will be better protected from future pandemics thanks to a landmark resolution brought by the UK and Argentina at the World Health Assembly (WHA) in Geneva today (Friday 27 May).

27 May 2022

Researchers focus on how bacterial cells adapt and resist antibiotics

Treatment of severe infections caused by pathogenic bacteria relies on ‘last resort’ antibiotics, but rising resistance by ‘superbugs’ to most clinically approved drugs leaves patients exposed to possible fatalities.

26 May 2022

Review addresses the need for innovative adjuvant approaches and delivery strategies for the advancement of new mucosal vaccines

Researchers reviewed available mucosal vaccines discussing the current challenges and ways to advance the existing approaches.

25 May 2022

UVA scientists make progress in their longstanding efforts to combat tuberculosis

As headlines focus on COVID-19 and, now, monkeypox, tuberculosis remains one of the great scourges of infectious disease around the world. Approximately 1.5 million people died of tuberculosis in 2020, the World Health Organization reports.

23 May 2022

Household contact management could help avert 20% of the multi-drug resistant TB cases in children

One in five multi-drug resistant (MDR) tuberculosis (TB) cases in children under the age of 15 could be averted every year by household contact management, according to a new modeling study published in The Lancet Global Health.

20 May 2022

STOP-COVID19 trial: Brensocatib did not improve clinical status of patients with severe SARS-CoV-2 infection

Brensocatib did not improve the clinical status of patients hospitalized with severe SARS-CoV-2 infection in the double-blind randomized, placebo-controlled STOP-COVID19 multicenter clinical trial, according to research published at the ATS 2022 international conference.

18 May 2022

Researchers use bacteriophages to treat antibiotic-resistant mycobacterial lung infection

For the first time, researchers have successfully used bacteriophages – viruses that kill bacteria – to treat an antibiotic-resistant mycobacterial lung infection, clearing the way for a young National Jewish Health patient with cystic fibrosis to receive a life-saving lung transplant.

13 May 2022

The 'Big Three' could benefit from the phenomenal strides in vaccine technology

Three historically neglected diseases - the 'Big Three', namely tuberculosis, malaria and HIV/AIDS- could be set to benefit from the phenomenal strides that have occurred in vaccine technology in the 2020s.

11 May 2022

A hybrid, multiscale, individual-based model to study the within-host spread of SARS-CoV-2 and the subsequent innate immune response

In this study, the authors have specifically studied the interactions of epithelial cells, a subset of cytokines and macrophages.

10 May 2022

Tuberculosis News and Research

Latest Tuberculosis News and Research

UB program secures $12.8 million to improve the quality of global HIV research

Early success of shorter tuberculosis treatment in Nigeria could pave the way for nationwide rollout

Inhaled vaccines provide better protection and stronger immunity than nasal sprays, study confirms

Pregnant people in Sub-Saharan Africa are at higher risk of complications and death from COVID-19

Highly sensitive blood test could give doctors a new tool to quickly identify and treat tuberculosis

Midwifery education in Bangladesh has greatly improved women’s access to safe childbirth, studies show

New class of antibiotics found to be highly effective against drug-resistant tuberculosis

UK-Argentina led resolution could lead to better protection from future pandemics

Researchers focus on how bacterial cells adapt and resist antibiotics

Review addresses the need for innovative adjuvant approaches and delivery strategies for the advancement of new mucosal vaccines

UVA scientists make progress in their longstanding efforts to combat tuberculosis

Household contact management could help avert 20% of the multi-drug resistant TB cases in children

STOP-COVID19 trial: Brensocatib did not improve clinical status of patients with severe SARS-CoV-2 infection

Researchers use bacteriophages to treat antibiotic-resistant mycobacterial lung infection

The 'Big Three' could benefit from the phenomenal strides in vaccine technology

A hybrid, multiscale, individual-based model to study the within-host spread of SARS-CoV-2 and the subsequent innate immune response

New genetic markers could improve early detection of drug-resistant tuberculosis

Researchers investigate IgG antibodies against Mtb proteins in an Asian elephant cured of tuberculosis

Evaluation of the potential of new and repurposed TB vaccines

Study identifies a protein in Mycobacterium tuberculosis that contributes to drug tolerance

Crying out for new disease diagnoses

Understanding the emotions behind memories

Sustainable Science; What does the future look like?

Tuberculosis News and Research

Latest Tuberculosis News and Research

Crying out for new disease diagnoses

Understanding the emotions behind memories

Sustainable Science; What does the future look like?

Newsletters you may be interested in